A multi-antigenic adenoviral-vectored vaccine improves BCG-induced protection of goats against pulmonary tuberculosis infection and prevents disease progression.
about
Assessment of BCG and inactivated Mycobacterium bovis vaccines in an experimental tuberculosis infection model in sheep.Effects of the fusion design and immunization route on the immunogenicity of Ag85A-Mtb32 in adenoviral vectored tuberculosis vaccine.CD8 T cells and Mycobacterium tuberculosis infection.Oral Vaccination with Heat-Inactivated Mycobacterium bovis Does Not Interfere with the Antemortem Diagnostic Techniques for Tuberculosis in Goats.Global Efforts in the Development of Vaccines for Tuberculosis: Requirements for Improved Vaccines Against Mycobacterium tuberculosis.Field evaluation of the efficacy of Mycobacterium bovis BCG vaccine against tuberculosis in goats.Serological Follow-up of Tuberculosis in a Wild Boar Population in Contact with Infected Cattle.Recombinant adenovirus expressing the haemagglutinin of Peste des petits ruminants virus (PPRV) protects goats against challenge with pathogenic virus; a DIVA vaccine for PPR.Boosting with recombinant MVA expressing M. tuberculosis α-crystallin antigen augments the protection imparted by BCG against tuberculosis in guinea pigs.Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?Efficacy of parenteral vaccination against tuberculosis with heat-inactivated Mycobacterium bovis in experimentally challenged goats.
P2860
Q33874162-8456BF74-28E0-40BB-A54C-127C24A48687Q35887146-D90AE9E7-AE10-4746-BF4A-D12C1B41AAEAQ38445065-2619E541-12C9-4BCD-8365-C5E463452253Q38639732-EE27A43F-AC0C-4514-9967-2659B37C722EQ38907507-4B73F652-FDAD-4C60-B705-EF367F5FC5B4Q40089619-678B4FF6-BEB0-4BD4-B82B-72F1D2D2D343Q41257045-6095176F-9B8B-4E4A-A81E-E3D888E73153Q41995734-FE30F26B-33EC-45CD-9F60-824DA8157633Q47155139-72A3DA4E-6D2A-4A67-A320-1A6F4DAF626BQ47834561-928E61BD-68E8-4166-8BA2-0440B63273D3Q55358753-88110456-123A-4716-9786-A36A960333DD
P2860
A multi-antigenic adenoviral-vectored vaccine improves BCG-induced protection of goats against pulmonary tuberculosis infection and prevents disease progression.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A multi-antigenic adenoviral-v ...... prevents disease progression.
@ast
A multi-antigenic adenoviral-v ...... prevents disease progression.
@en
type
label
A multi-antigenic adenoviral-v ...... prevents disease progression.
@ast
A multi-antigenic adenoviral-v ...... prevents disease progression.
@en
prefLabel
A multi-antigenic adenoviral-v ...... prevents disease progression.
@ast
A multi-antigenic adenoviral-v ...... prevents disease progression.
@en
P2093
P2860
P50
P921
P1433
P1476
A multi-antigenic adenoviral-v ...... prevents disease progression.
@en
P2093
Anna Andaluz
Bernardo Villarreal-Ramos
H Martin Vordermeier
Maite Martín
Mariano Domingo
Miquel Nofrarías
P2860
P304
P356
10.1371/JOURNAL.PONE.0081317
P407
P577
2013-11-21T00:00:00Z